Contact us Find a person

News

Donate

Donate

News

bg-very-light-peach

Our work

Health themes

Alcohol and other drugs Health emergencies and pandemic response Healthy ageing and non-communicable diseases Hepatitis B and C HIV Malaria and other mosquito-borne diseases Sexual and reproductive health Tuberculosis, COVID-19 and other airborne pathogens Women's and children's health Young people's health

Projects

All projects Student opportunities Flagship initiatives

Published research

Publications

bg-type-careers

Careers and study

Careers

Open positions Career pathways

Study at Burnet

Projects open to students

Working at Burnet

bg-very-light-peach

News

bg-type-support

Support us

Appeals Donating for individuals Monthly giving Giving in Wills and bequests Trusts and foundations Corporate supporters Endowment giving Supporter stories Thanks to You newsletter

Across the Pacific region, HIV is claiming more lives than ever

bg-very-light-peach

Commercialisation

Partner with us Vaccines Diagnostics Microbiome Stellabody® technology Ageing and inflammation Burnext accelerator program

Current partnering opportunities

bg-very-light-peach

About us

About us

Our history Our people and structure Working groups Annual and financial reports Policies plans and strategies Awards and scholarships Contact us

Where we work

Australia Myanmar Papua New Guinea Around the world

Contact us Find a person

bg-surface-tint

Our work

Health themes

Alcohol and other drugs Health emergencies and pandemic response Healthy ageing and non-communicable diseases Hepatitis B and C HIV Malaria and other mosquito-borne diseases Sexual and reproductive health Tuberculosis, COVID-19 and other airborne pathogens Women's and children's health Young people's health

Projects

All projects Student opportunities Flagship initiatives

Published research

Publications

bg-surface-tint

Careers and study

Careers

Open positions Career pathways

Study at Burnet

Projects open to students

Working at Burnet

bg-surface-tint

News

bg-surface-tint

Support us

Appeals Donating for individuals Monthly giving Giving in Wills and bequests Trusts and foundations Corporate supporters Endowment giving Supporter stories Thanks to You newsletter

Across the Pacific region, HIV is claiming more lives than ever

bg-surface-tint

Commercialisation

Partner with us Vaccines Diagnostics Microbiome Stellabody® technology Ageing and inflammation Burnext accelerator program

Current partnering opportunities

bg-surface-tint

About us

About us

Our history Our people and structure Working groups Annual and financial reports Policies plans and strategies Awards and scholarships Contact us

Where we work

Australia Myanmar Papua New Guinea Around the world

/
News /
Phase Two in addressing antimicrobial resistance in PNG

Amr Png 600X600

Published 23 April 2024

Phase Two in addressing antimicrobial resistance in PNG

People

Professor Robert Power AM

Fleming Fund Program Director; Project Consultant

Subscribe to our newsletter

Follow us

Our work

Health themes Projects Published research

Careers and study

Careers Study at Burnet

News

Support us

Appeals Donating for individuals Monthly giving Giving in Wills and bequests Trusts and foundations Corporate supporters Endowment giving Supporter stories Thanks to You newsletter

Commercialisation

Partner with us Vaccines Diagnostics Microbiome Stellabody® technology Ageing and inflammation Burnext accelerator program

About us

Our history Our people and structure Annual and financial reports Policies plans and strategies Awards and scholarships Where we work Contact us

Privacy Policy Contact us Copyright and disclaimer Accessibility

Burnet Institute (Australia) is located on the traditional land of the Boon Wurrung people and we offer our respects to their Elders past and present. We recognise and respect the continuation of cultural, spiritual and educational practices of Aboriginal and Torres Strait Islander peoples of this land.

Disclosure of interest

Burnet Institute is an independent medical research institute and like other medical research institutes in Victoria, receives competitive funding support for its research programs from many sources including the National Health and Medical Research Council, Medical Research Future Fund, Operational Infrastructure Support Scheme of the State Government of Victoria, Victorian Medical Research Accelerator Fund, as well as the Department of Foreign Affairs and Trade, philanthropic support from the Australian community, and various national and international Trusts and Foundations.

Burnet Institute owns registered trademarks to its name and pending trademarks to the ‘reach for the many’ logo and word marks found on our website.

ABN 269108811

© The Macfarlane Burnet Institute for Medical Research and Public Health Ltd, 2025. All rights reserved.